Browsing: GLP1

Medifast, Inc. (NYSE:), a leading health and wellness company, reported a significant decrease in first-quarter revenue during its 2024 earnings…

GLP-1 receptor agonists are changing the way chronic conditions like type 2 diabetes are managed, but they have also been…